Infectious complications of percutaneous vascular closure devices

Mayo Clinic Proceedings

Volumn 80, Issue 8, 2005, Pages 1011-1015

  Sohail, Muhammad R ^a   Khan, Akbar H ^a   Holmes Jr , David R ^a   Wilson, Walter R ^a   Steckelberg, James M ^a   Baddour, Larry M ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFEPIME; CIPROFLOXACIN; NAFCILLIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; COMORBIDITY; DATA BASE; DEBRIDEMENT; DEVICE INFECTION; DIABETES MELLITUS; EDEMA; ERYTHEMA; FALSE ANEURYSM; FEVER; HUMAN; LANGUAGE; MEDICAL INSTRUMENTATION; MEDICAL LITERATURE; MORTALITY; MYCOTIC ANEURYSM; OBESITY; PAIN; PERCUTANEOUS VASCULAR CLOSURE DEVICE; PUS; RETROSPECTIVE STUDY; REVIEW; STAPHYLOCOCCUS AUREUS; SYMPTOM; SYSTEMATIC REVIEW; UNITED STATES; VASCULAR SURGERY;

EID: 23244444498     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/80.8.1011     Document Type: Article

References (33)

1. Johanning JM, Franklin DP, Elmore JR, Han DC. Femoral artery infections associated with percutaneous arterial closure devices. J Vasc Surg. 2001;34:983-985.
2. Baim DS, Knopf WD, Hinohara T, et al. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials. Am J Cardiol. 2000;85:864-869.
3. Gerckens U, Cattelaens N, Lampe EG, Grube E. Management of arterial puncture site after catheterization procedures: evaluating a suture-mediated closure device. Am J Cardiol. 1999;83:1658-1663.
4. Hoffer EK, Bloch RD. Percutaneous arterial closure devices. J Vasc Interv Radiol. 2003;14:865-885.
5. Smith TP, Cruz CP, Moursi MM, Eidt JF. Infectious complications resulting from use of hemostatic puncture closure devices. Am J Surg. 2001;182:658-662.
6. Carey D, Martin JR, Moore CA, Valentine MC, Nygaard TW. Complications of femoral artery closure devices. Catheter Cardiovasc Interv. 2001;52:3-7.
7. Eidt JF, Habibipour S, Saucedo JF, et al. Surgical complications from hemostatic puncture closure devices. Am J Surg. 1999;178:511-516.
8. Cooper CL, Miller A. Infectious complications related to the use of the angio-seal hemostatic puncture closure device. Catheter Cardiovasc Interv. 1999;48:301-303.
9. Cherr GS, Travis JA, Ligush J Jr, et al. Infection is an unusual but serious complication of a femoral artery catheterization site closure device. Ann Vasc Surg. 2001;15:567-570.
10. Ward SR, Casale P, Raymond R, Kussmaul WG HI, Simpfendorfer C, Angio-Seal Investigators. Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Am J Cardiol. 1998; 81:569-572.
11. Cura FA, Kapadia SR, L'Allier PL, et al. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. Am J Cardiol. 2000;86:780-782, A789.
12. von Hoch F, Neumann FJ, Theiss W, Kastrati A, Schomig A. Efficacy and safety of collagen implants for haemostasis of the vascular access site after coronary balloon angioplasty and coronary stem implantation: a randomized study. Eur Heart J. 1995;16:640-646.
13. Pipkin W, Brophy C, Nesbit R, Mondy JS III. Early experience with infectious complications of percutaneous femoral artery closure devices. J Vasc Surg. 2000;32:205-208.
14. Whitton Hollis H Jr, Rehring TF. Femoral endarteritis associated with percutaneous suture closure: new technology, challenging complications. J Vasc Surg. 2003;38:83-87.
15. Yamamoto N, Koyano K, Azuma M, Ochiai H, Kashiwabara T. Groin infection caused by a percutaneous femoral artery closure device: report of a case. Surg Today. 2003;33:801-804.
16. Geary K, Landers JT, Fiore W, Riggs P. Management of infected femoral closure devices. Cardiovasc Surg. 2002;10:161-163.
17. Heck DV, Muldowney S, McPherson SH. Infectious complications of perclose for closure of femoral artery punctures [letter]. J Vasc Interv Radiol. 2002;13:430-431.
18. Toursarkissian B, Mejia A, Smilanich RP, Shireman PK, Sykes MT. Changing patterns of access site complications with the use of percutaneous closure devices. Vasc Surg. 2001;35:203-206.
19. Sprouse LR II, Botta DM Jr, Hamilton IN Jr. The management of peripheral vascular complications associated with the use of percutaneous suture-mediated closure devices. J Vasc Surg. 2001;33:688-693.
20. Wilson JS, Johnson BL, Parker JL, Back MR, Bandyk DF. Management of vascular complications following femoral artery catheterization with and without percutaneous arterial closure devices. Ann Vasc Surg. 2002;16:597-600.
21. Noguchi T, Miyazaki S, Yasuda S, et al. A randomised controlled trial of Prostar Plus for haemostasis in patients after coronary angioplasty. Eur J Vasc Endovasc Surg. 2000;19:451-455.
22. Rinder MR, Tamirisa PK, Taniuchi M, Kurz HI, Mumm K, Lasala JM. Safety and efficacy of suture-mediated closure after percutaneous coronary interventions. Catheter Cardiovasc Interv. 2001;54:146-151.
23. Tolerico PH, McKendall GR. Femoral endarteritis as a complication of percutaneous coronary intervention. J Invasive Cardiol. 2000;12:155-157.
24. Duffin DC, Muhlestein JB, Allisson SB, et al. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invasive Cardiol. 2001;13:354-362.
25. Tan SL. Explantation of infected hemostatic puncture closure devices: a case report. Vasc Surg. 1999;33:507-510.
26. Sanbora TA, Gibbs HH, Brinker JA, Knopf WD, Kosinski EJ, Roubin GS. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol. 1993;22:1273-1279.
27. Boston US, Panneton JM, Hofer JM, et al. Infectious and ischemic complications from percutaneous closure devices used after vascular access. Ann Vasc Surg. 2003;17:66-71.
28. Pracyk JB, Wall TC, Longabaugh JP, et al. A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention. Am J Cardiol. 1998;81:970-976.
29. Cowley MJ, Mullin SM, Kelsey SF, et al. Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry. Circulation. 1985;71:90-97.
30. Cleveland KO, Gelfand MS, Invasive staphylococcal infections complicating percutaneous transluminal coronary angioplasty: three cases and review. Clin Infect Dis. 1995;21:93-96.
31. Eggebrecht H, Haude M, Baumgart D, Erbel R. Infectious complications related to the use of the angio-seal hemostatic puncture closure device [letter]. Catheter Cardiovasc Interv. 2000;49:352-353.
32. Baddour LM, Bettmann MA, Bolger AF, et al, American Heart Association. Nonvalvular cardiovascular device-related infections. Circulation. 2003; 108:2015-2031.
33. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339-343.